Diabetic Peripheral Neuropathy (DPN)


Up to $250


Diabetic Peripheral Neuropathy

Official Title

Diabetic Peripheral Neuropathy Study I

Study Summary

To evaluate the efficacy of multiple dose levels of NYX-2925 versus placebo in treating the neuropathic pain associated with Diabetic Peripheral Neuropathy.

Eligibility and Recruitment Information

Recruitment Status Recruiting
Eligible Genders Both
Eligible Ages 18-70
Inclusion Diagnosed with Type 2 Diabetes.
Exclusion History of sever renal impairment defined by renal dialysis or peritoneal dialysis, or who have undergone renal transplant.
Start Date
Compensation Up to $250 USD
Location Orlando, FL

Study Information

Condition Diabetic Peripheral Neuropathy (DPN)
Study Phase Phase 2

Administrative Information

Study ID NCT03219320
Investigators Judith White, MD

Apply for this study

Please include your first name.
Please include your last name.
Please include a valid email address.
Thank you for applying.
Sorry, something wen't wrong. Please contact us for support.